NASDAQ:PETS PetMed Express - PETS Stock Forecast, Price & News Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding PetMed Express, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. $21.85 +0.52 (+2.44%) (As of 01/31/2023 11:39 AM ET) Add Compare Share Share Today's Range$21.18▼$21.8850-Day Range$17.16▼$21.5252-Week Range$17.08▼$29.53Volume74,125 shsAverage Volume338,546 shsMarket Capitalization$460.60 millionP/E Ratio28.01Dividend Yield5.58%Price Target$18.00 ProfileAnalyst RatingsChartCompetitorsDividendEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial Media PetMed Express MarketRank™ ForecastAnalyst RatingReduce1.00 Rating ScoreUpside/Downside15.6% Downside$18.00 Price TargetShort InterestBearish19.92% of Float Sold ShortDividend StrengthWeakBased on Four FactorsSustainabilityN/ANews Sentiment0.90Based on 5 Articles This WeekInsider TradingN/AProj. Earnings Growth16.00%From $0.75 to $0.87 Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.1.65 out of 5 starsRetail/Wholesale Sector182nd out of 216 stocksDrug Stores & Proprietary Stores Industry4th out of 5 stocks 0.5 Analyst's Opinion Consensus RatingPetMed Express has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no buy ratings, no hold ratings, and 1 sell rating.Price Target Upside/DownsideAccording to analysts' consensus price target of $18.00, PetMed Express has a forecasted downside of 15.6% from its current price of $21.33.Amount of Analyst CoveragePetMed Express has only been the subject of 1 research reports in the past 90 days. Previous Next 1.0 Short Interest Percentage of Shares Shorted19.92% of the float of PetMed Express has been sold short.Short Interest Ratio / Days to CoverPetMed Express has a short interest ratio ("days to cover") of 11.8, which indicates bearish sentiment.Change versus previous monthShort interest in PetMed Express has recently decreased by 0.74%, indicating that investor sentiment is improving. Previous Next 1.7 Dividend Strength Dividend LeadershipPetMed Express is a leading dividend payer. It pays a dividend yield of 5.58%, putting its dividend yield in the top 25% of dividend-paying stocks.Dividend GrowthPetMed Express does not have a long track record of dividend growth.Dividend CoverageThe dividend payout ratio of PetMed Express is 153.85%. Payout ratios above 75% are not desirable because they may not be sustainable.Dividend SustainabilityBased on EPS estimates, PetMed Express will have a dividend payout ratio of 137.93% in the coming year. This indicates that PetMed Express may not be able to sustain their current dividend. Previous Next N/A Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreThere is no current Upright™ data available for PETS. Previous Next 2.7 News and Social Media Coverage News SentimentPetMed Express has a news sentiment score of 0.90. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.52 average news sentiment score of Retail/Wholesale companies.News Coverage This WeekMarketBeat has tracked 5 news articles for PetMed Express this week, compared to 3 articles on an average week.Search InterestOnly 3 people have searched for PETS on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.MarketBeat FollowsOnly 4 people have added PetMed Express to their MarketBeat watchlist in the last 30 days. This is a decrease of 0% compared to the previous 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, PetMed Express insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 4.10% of the stock of PetMed Express is held by insiders.Percentage Held by Institutions77.74% of the stock of PetMed Express is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 3.1 Earnings and Valuation Earnings GrowthEarnings for PetMed Express are expected to grow by 16.00% in the coming year, from $0.75 to $0.87 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of PetMed Express is 27.35, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 127.01.Price to Earnings Ratio vs. SectorThe P/E ratio of PetMed Express is 27.35, which means that it is trading at a less expensive P/E ratio than the Retail/Wholesale sector average P/E ratio of about 37.90.Price to Book Value per Share RatioPetMed Express has a P/B Ratio of 3.15. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About PetMed Express (NASDAQ:PETS) StockPetMed Express, Inc. engages in the provision of markets prescription and non-prescription pet medications, health products and supplies for dogs and cats. Its non-prescription medications include flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies. The prescription medications include heartworm preventatives, arthritis, thyroid, diabetes and pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The firm markets its products through national television, online and direct mail or print advertising campaigns. The company was founded in January 1996 and is headquartered in Delray Beach, FL.Read More Receive PETS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for PetMed Express and its competitors with MarketBeat's FREE daily newsletter. Email Address PETS Stock News HeadlinesJanuary 31, 2023 | finance.yahoo.comPets at Home sees FY 2023 underlying pretax profit at upper end of consensusJanuary 30, 2023 | finance.yahoo.comIs PetMed Express, Inc.'s (NASDAQ:PETS) Recent Stock Performance Influenced By Its Fundamentals In Any Way?January 31, 2023 | Investing Trends (Ad)GRAPHITE: "Essential for America's National Defense"Did you know each EV battery contains up to 220 pounds of graphite and China controls more than 90% of the world's graphite trade? But now that the U.S. has classified it as "essential for America's National Defense"... one little-known company could become America's ONLY fully integrated graphite provider. January 25, 2023 | seekingalpha.comPETS PetMed Express, Inc.January 23, 2023 | finance.yahoo.comPetMed Express, Inc. Sets Third Quarter 2022 Earnings CallJanuary 18, 2023 | msn.comPeople are abandoning pets at airports. Don’t be like them.January 18, 2023 | marketwatch.comPets Digestive Enzymes Market Size 2023 : Expected To Deliver Dynamic Progression Until 2028January 17, 2023 | finance.yahoo.comPetMed Express buys PetCareRX for $36MJanuary 31, 2023 | Investing Trends (Ad)Without Graphite, There Would Be ZERO EV Batteries!Investors constantly hear that lithium is the key to powering the transition to green energy. Truth is, today's EV batteries contain more graphite in volume than any other essential ingredients.January 17, 2023 | msn.comDogs day out: Pets walk the ramp at Kolkata carnival | See picsJanuary 17, 2023 | markets.businessinsider.comPetMed Agrees To Acquire PetCareRxJanuary 17, 2023 | forbes.comPetMeds Expands Its Reach With Acquisition Of PetCareRxJanuary 17, 2023 | finance.yahoo.comPetMeds® to Acquire PetCareRxJanuary 17, 2023 | marketwatch.comPet Care E-commerce Market, Leading Players, Growth and Business Opportunities by 2029January 16, 2023 | marketwatch.comRecycled PET (r-PET) Bottles Market 2023 Comes with a Detailed Analysis of Industry Trends till 2028 [ LATEST REPORT ]January 16, 2023 | marketwatch.comPet Food Flavors Market Market Size 2023 Industry Analysis, Key Players, Regional Demand, Opportunity and Forecast 2029January 15, 2023 | marketwatch.comPositron Emission Tomography (PET) Market Size 2023 with Rising Demand, ultimatum for the market plannedJanuary 14, 2023 | marketwatch.comPET-CT Scanning Market Size, Share, Growth, Revenue, Demand, Future Potential, and Forecast from 2023 to 2028January 13, 2023 | marketwatch.comInsect Protein Feed For Pets Market Outlook and Forecast 2023 To 2029 with Top Countries DataJanuary 11, 2023 | benzinga.comPetMeds® and Vetster to Participate in the 40th VMX Veterinary Meeting & ExpoJanuary 8, 2023 | finance.yahoo.comThis Under-the-Radar E-Commerce Stock Is Aiming to Expand Its MarketDecember 30, 2022 | finance.yahoo.comPetMed Express, Inc. (NASDAQ:PETS) is largely controlled by institutional shareholders who own 81% of the companyDecember 24, 2022 | forbes.comBest Cheap Pet Insurance Of 2022December 23, 2022 | marketwatch.comGlobal PET Preform Machine Market 2023: Industry Research Report, Competitive Landscape, Regional Status and Growth Prospect to 2028December 22, 2022 | marketwatch.comPet Supplements Market [ New Report ] Global Industry Analysis with Growth for New Players & Forecast 2023-2027December 22, 2022 | marketwatch.comPet Care E-commerce Market Size and Share Likely to Grow with CAGR Status and Industry Revenue Forecast by 2023-2029December 20, 2022 | marketwatch.comPet Toys and Training Service Market Size In Depth Analysis 2023 with Prime Manufactures & Top Countries Data, Forecast Timeframe 2026See More Headlines View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart Receive PETS Stock News and Ratings via Email Sign-up to receive the latest news and ratings for PetMed Express and its competitors with MarketBeat's FREE daily newsletter. Email Address PETS Company Calendar Last Earnings11/07/2022Ex-Dividend for 11/30 Dividend11/17/2022Dividend Payable11/30/2022Today1/31/2023Next Earnings (Confirmed)2/06/2023Fiscal Year End3/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Drug stores & proprietary stores Sub-IndustryInternet Retail SectorRetail/Wholesale Current SymbolNASDAQ:PETS CUSIP71638210 CIK1040130 Webwww.1800petmeds.com Phone(561) 526-4444Fax561-526-4445Employees219Year Founded1996Price Target and Rating Average Stock Price Forecast$18.00 High Stock Price Forecast$18.00 Low Stock Price Forecast$18.00 Forecasted Upside/Downside-17.6%Consensus RatingReduce Rating Score (0-4)1.00 Research Coverage1 Analysts Profitability EPS (Most Recent Fiscal Year)$0.78 Trailing P/E Ratio28.01 Forward P/E Ratio29.13 P/E GrowthN/ANet Income$21.10 million Net Margins5.98% Pretax Margin7.76% Return on Equity11.17% Return on Assets9.24% Debt Debt-to-Equity RatioN/A Current Ratio4.52 Quick Ratio3.41 Sales & Book Value Annual Sales$273.42 million Price / Sales1.68 Cash Flow$1.19 per share Price / Cash Flow18.39 Book Value$6.78 per share Price / Book3.22Miscellaneous Outstanding Shares21,080,000Free Float20,212,000Market Cap$460.60 million OptionableOptionable Beta0.59 Social Links Key ExecutivesMatthew N. HulettPresident, Chief Executive Officer & DirectorChristine ChambersChief Financial OfficerMark MoseleyChief Technology & Information OfficerCarolyn CardenVice President-Product ManagementEddie KhoriatyDir-Pharmacy Services & Prescription Dept. ManagerKey CompetitorsRite AidNYSE:RADEl Pollo LocoNASDAQ:LOCOBrilliant Earth GroupNASDAQ:BRLTDestination XL GroupNASDAQ:DXLGContextLogicNASDAQ:WISHView All CompetitorsInsiders & InstitutionsJames Investment Research Inc.Sold 13,466 shares on 1/30/2023Ownership: 0.079%Exchange Traded Concepts LLCBought 1,842 shares on 1/27/2023Ownership: 0.099%Comerica BankSold 3,838 shares on 1/26/2023Ownership: 0.059%Inlet Private Wealth LLCSold 48,050 shares on 1/23/2023Ownership: 0.189%Allspring Global Investments Holdings LLCSold 2,432 shares on 1/23/2023Ownership: 0.022%View All Institutional Transactions PETS Stock - Frequently Asked Questions Should I buy or sell PetMed Express stock right now? 1 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for PetMed Express in the last year. There are currently 1 sell rating for the stock. The consensus among Wall Street research analysts is that investors should "sell" PETS shares. View PETS analyst ratings or view top-rated stocks. What is PetMed Express' stock price forecast for 2023? 1 analysts have issued twelve-month price objectives for PetMed Express' shares. Their PETS share price forecasts range from $18.00 to $18.00. On average, they expect the company's share price to reach $18.00 in the next year. This suggests that the stock has a possible downside of 15.6%. View analysts price targets for PETS or view top-rated stocks among Wall Street analysts. How have PETS shares performed in 2023? PetMed Express' stock was trading at $17.70 on January 1st, 2023. Since then, PETS shares have increased by 20.5% and is now trading at $21.33. View the best growth stocks for 2023 here. When is PetMed Express' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Monday, February 6th 2023. View our PETS earnings forecast. How can I listen to PetMed Express' earnings call? PetMed Express will be holding an earnings conference call on Monday, February 6th at 4:30 PM Eastern. Interested parties can register for or listen to the call using this link or dial in at 412-317-6671 with passcode "13735907". How were PetMed Express' earnings last quarter? PetMed Express, Inc. (NASDAQ:PETS) posted its earnings results on Monday, November, 7th. The company reported $0.13 earnings per share for the quarter, missing the consensus estimate of $0.27 by $0.14. The business had revenue of $65.39 million for the quarter, compared to analysts' expectations of $65 million. PetMed Express had a trailing twelve-month return on equity of 11.17% and a net margin of 5.98%. How often does PetMed Express pay dividends? What is the dividend yield for PetMed Express? PetMed Express declared a quarterly dividend on Monday, November 7th. Investors of record on Friday, November 18th will be paid a dividend of $0.30 per share on Wednesday, November 30th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 5.63%. The ex-dividend date is Thursday, November 17th. Read our dividend analysis for PETS. Is PetMed Express a good dividend stock? PetMed Express (NASDAQ:PETS) pays an annual dividend of $1.20 per share and currently has a dividend yield of 5.58%. PETS has a dividend yield higher than 75% of all dividend-paying stocks, making it a leading dividend payer. The dividend payout ratio is 153.85%. Payout ratios above 75% are not desirable because they may not be sustainable. Based on EPS estimates, PETS will have a dividend payout ratio of 137.93% in the coming year. This indicates that the company may not be able to sustain their current dividend. Read our dividend analysis for PETS. What is Mendo Akdag's approval rating as PetMed Express' CEO? 5 employees have rated PetMed Express Chief Executive Officer Mendo Akdag on Glassdoor.com. Mendo Akdag has an approval rating of 46% among the company's employees. This puts Mendo Akdag in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of PetMed Express own? Based on aggregate information from My MarketBeat watchlists, some companies that other PetMed Express investors own include Intel (INTC), NVIDIA (NVDA), AT&T (T), Cisco Systems (CSCO), Alibaba Group (BABA), Gilead Sciences (GILD), Advanced Micro Devices (AMD), Verizon Communications (VZ), Netflix (NFLX) and Micron Technology (MU). What is PetMed Express' stock symbol? PetMed Express trades on the NASDAQ under the ticker symbol "PETS." Who are PetMed Express' major shareholders? PetMed Express' stock is owned by a variety of institutional and retail investors. Top institutional investors include North Star Investment Management Corp. (0.25%), Inlet Private Wealth LLC (0.19%), Exchange Traded Concepts LLC (0.10%), Exchange Traded Concepts LLC (0.10%), James Investment Research Inc. (0.08%) and Yousif Capital Management LLC (0.06%). Insiders that own company stock include Bruce S Rosenbloom, Gian Fulgoni, Menderes Akdag and Ronald J Korn. View institutional ownership trends. How do I buy shares of PetMed Express? Shares of PETS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is PetMed Express' stock price today? One share of PETS stock can currently be purchased for approximately $21.33. How much money does PetMed Express make? PetMed Express (NASDAQ:PETS) has a market capitalization of $449.64 million and generates $273.42 million in revenue each year. The company earns $21.10 million in net income (profit) each year or $0.78 on an earnings per share basis. How many employees does PetMed Express have? The company employs 219 workers across the globe. How can I contact PetMed Express? PetMed Express' mailing address is 420 SOUTH CONGRESS AVENUE, DELRAY BEACH FL, 33445. The official website for the company is www.1800petmeds.com. The company can be reached via phone at (561) 526-4444, via email at investor@petmeds.com, or via fax at 561-526-4445. This page (NASDAQ:PETS) was last updated on 1/31/2023 by MarketBeat.com Staff Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.